$INO Recent News Monday's biggest gaining and declining

New Post Public Reply Private Reply Replies (0) Message Board

Jan 8, 2014 at 12:57 PM

$INO Recent News

Monday's biggest gaining and declining stocks 4:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 11:31 a.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 9:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 10:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 5:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 5:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 4:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 5:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 5:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 9:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 6:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 6:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 9:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 5:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 5:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 5:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 5:05 a.m. May 12, 2005 - Steve Goldstein

Mid-Afternoon Market Update: Markets Mixed as Airlines Show a Boost in Traffic 2:31 p.m. Jan. 3, 2014 - benzinga.com
Inovio, Chelsea struggle after Feuerstein mention 11:58 a.m. Jan. 3, 2014 - Seeking Alpha
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Today's Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 9:48 a.m. Dec. 27, 2013 - TheStreet.com
Inovio Pharmaceuticals (INO) Soars: Stock Zooms 20.2% - Tale of the Tape 8:51 a.m. Dec. 27, 2013 - Zacks.com
Arena, Inovio rally after positive mention 10:57 a.m. Dec. 26, 2013 - Seeking Alpha
3 Biotechs That Could Double In 2014 8:48 a.m. Dec. 26, 2013 - Seeking Alpha
These Small-Cap BioPharma Companies Have Catalysts Upcoming 8:59 a.m. Dec. 23, 2013 - Seeking Alpha
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014 11:30 a.m. Dec. 20, 2013 - Seeking Alpha
Buy Inovio Due To Insider Interest And Upcoming Trial Results 8:21 a.m. Dec. 19, 2013 - Seeking Alpha
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting 1:46 p.m. Dec. 17, 2013 - Seeking Alpha
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem 9:14 a.m. Dec. 4, 2013 - Seeking Alpha
2 Small Speculative Biotech Plays Moving On News 9:55 a.m. Nov. 21, 2013 - Seeking Alpha
Insider Interest, Positive Trial Data And Upcoming Catalysts, Everything Is Going For In 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
UNIS Stock Explodes By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Inovio Pharma jumps on MERS vaccine news 8:22 a.m. Nov. 20, 2013 - Seeking Alpha
Inovio Pharmaceutical's DNA Vaccine for MERS Virus Shows Promising Results in Preclinical Trial 4:44 a.m. Nov. 20, 2013 - benzinga.com
Insider Trading Alert - INO, PSMT, CBI, BRS And EHTH Traded By Insiders 12:02 p.m. Nov. 15, 2013 - TheStreet.com
Treating Melanoma: Only The Best Shall Survive 3:31 p.m. Nov. 13, 2013 - Seeking Alpha

Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference 4:00 a.m. Jan. 6, 2014 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 8:23 a.m. Dec. 17, 2013 - PR Newswire
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel 8:05 a.m. Dec. 11, 2013 - PR Newswire
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial 3:05 a.m. Nov. 20, 2013 - PR Newswire
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:03 a.m. Nov. 19, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees 4:00 a.m. Nov. 19, 2013 - PR Newswire
International Vaccine Institute Announces Appointments of New Members to its Board of Trustees 8:00 p.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences 4:00 a.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Receives 2013 Drug Discovery & Achievement Award 12:00 a.m. Nov. 14, 2013 - PR Newswire
Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results 6:33 a.m. Nov. 12, 2013 - PR Newswire
Inovio Pharmaceuticals to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013 9:32 a.m. Nov. 11, 2013 - ACCESSWIRE
Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 12, 2013 4:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial 3:00 a.m. Oct. 21, 2013 - PR Newswire
Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc. 8:27 a.m. Oct. 4, 2013 - PR Newswire
Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum 3:00 a.m. Oct. 1, 2013 - PR Newswire
Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies 4:12 a.m. Sept. 24, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles 3:00 a.m. Sept. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership with Roche 3:10 a.m. Sept. 10, 2013 - PR Newswire
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products 3:00 a.m. Sept. 10, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hehe Forum Stirs Global Harmony in Taizhou, China

Reflecting on Hehe Culture's Impact Seems like everyone and their neighbor are flocking to Taizhou for the annual Hehe Culture Forum. It's not your run-of-the-mill gathering; more than 220 folks from 23 different countries showed up, diving deep into the murky waters of cultural exchange, global governance, and international cooperation. Now, if you think it's just...

ASE Technology Shows Strong Growth in Q3 Financials

Taipei's Semiconductor Giant Surging Ahead You wanna talk about growth? ASE Technology Holding Co. just posted some fire results for their third quarter of 2026. Revenues screaming to NT$244,161 million, that's a tidy 44.8% jump year-over-year, and even 27.8% more than they grabbed last quarter. Call me old school, but I do love when a company's financials tell a tale of...

Travelers Juggle Cash and Cards Abroad: Survey Insights

Travel Spending: Balancing Convenience with Costs Navigating the financial landscape when you're a traveler abroad ain't always a walk in the park, folks. A fresh survey by Upgraded Points takes a gritty dive into how 1,500 globe-trotters juggle cash and cards while hopping across borders. The nitty-gritty? Messy exchange rates, sneaky fees, and the dreaded declined...

Why Ghosts Don’t Spook Homebuyers Anymore

By Caleb Price Updated Oct 28, 2026 Category News Views 169

Haunted Houses—A New Norm in Real Estate? In what's becoming a spooky trend in real estate, more than half of Americans are game for buying haunted houses. Imagine that! Suddenly, Casper and his ghostly pals are claiming space in the housing market. With home prices soaring, folks are getting creative. Could a phantasmal presence really tip the scales for cash-strapped...

California Credit Union's Student Account Banks Big Goals

Financial Education for the Next Generation Here's the deal—credit unions aren't often the star of anyone's morning chat over a sloppy diner breakfast, but California Credit Union might just deserve a spotlight today. They've bagged the national Bank On certification for their Student Checking account. That means they’ve hit the jackpot in terms of meeting the...

CATL's Bold Move: New Energy Storage Game Changer

Fresh Energy on the Aussie Horizon Ever see a heavyweight step into the ring and know it's about to shake things up? That's CATL breaking into Australia with their new TENER+ system. This ain't just talk—these guys are delivering ultra-high capacity energy storage aimed right at the heart of the Australian energy sector, just in time for All Energy 2026. A Big Play in...

5W Lauded by Inc.'s Power Partner Awards in 2026

5W's Ascent in the PR World Who'd have thought a PR firm would bask in the limelight like this? 5W, a key player in the public relations jungle, is bagging recognition from Inc.'s Power Partner Awards this year. These awards aren't handed out like free samples; they're a shoutout to those who truly matter to businesses aiming for the stars. A Powerhouse of Visibility and...

Army Embraces HAVIK Kits for Modern Fires Training

HAVIK Fires Into Army's Training Arsenal Well, folks, here we go again with some powerhouse corporate moves in the defense sector. The U.S. Army's grabbed a piece of HAVIK's pie, rolling out their ATLAS and SCOUT kits for their much-anticipated Fires simulation. Right off the bat, this isn't just another contract; it's a real game-changer in the Soldier Virtual Trainer...

Abbe Lane's Estate Auction: Glamour Up for Grabs

Glamour from the Mid-Century Comes to the Auction Block In a world obsessed with the flavor of the month, a collection that truly turns heads by sailing in on a wave of genuine mid-century splendor isn't something you stumble upon every day. John Moran Auctioneers has the privilege to crack open the vault on the Estate of Abbe Lane, a name that once rolled off tongues...

Pozdeutinurad Phase 3 Success Impact on Sobi and Market

Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...